IL88963A - Circular synthetic peptides and their mixtures for the detection of VIH antibodies and for the formation of vaccines - Google Patents

Circular synthetic peptides and their mixtures for the detection of VIH antibodies and for the formation of vaccines

Info

Publication number
IL88963A
IL88963A IL8896389A IL8896389A IL88963A IL 88963 A IL88963 A IL 88963A IL 8896389 A IL8896389 A IL 8896389A IL 8896389 A IL8896389 A IL 8896389A IL 88963 A IL88963 A IL 88963A
Authority
IL
Israel
Prior art keywords
peptide
hiv
amino acid
peptides
formula
Prior art date
Application number
IL8896389A
Other languages
English (en)
Hebrew (he)
Other versions
IL88963A0 (en
Original Assignee
Iaf Biochem Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27386744&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL88963(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/148,821 external-priority patent/US6218102B1/en
Priority claimed from US07/281,205 external-priority patent/US6214537B1/en
Application filed by Iaf Biochem Int filed Critical Iaf Biochem Int
Publication of IL88963A0 publication Critical patent/IL88963A0/xx
Publication of IL88963A publication Critical patent/IL88963A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • G01N33/56988HIV or HTLV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL8896389A 1988-01-27 1989-01-16 Circular synthetic peptides and their mixtures for the detection of VIH antibodies and for the formation of vaccines IL88963A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/148,821 US6218102B1 (en) 1988-01-27 1988-01-27 Synthetic peptides and mixtures thereof for detecting HIV antibodies
US18551888A 1988-04-22 1988-04-22
US07/281,205 US6214537B1 (en) 1988-01-27 1988-12-08 Synthetic peptides and mixtures thereof for detecting HIV antibodies

Publications (2)

Publication Number Publication Date
IL88963A0 IL88963A0 (en) 1989-08-15
IL88963A true IL88963A (en) 1996-05-14

Family

ID=27386744

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8896389A IL88963A (en) 1988-01-27 1989-01-16 Circular synthetic peptides and their mixtures for the detection of VIH antibodies and for the formation of vaccines

Country Status (7)

Country Link
EP (1) EP0326490B2 (de)
JP (3) JPH01224397A (de)
AT (1) ATE131492T1 (de)
AU (1) AU629528B2 (de)
DE (1) DE68925043T3 (de)
ES (1) ES2083387T5 (de)
IL (1) IL88963A (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5241047A (en) * 1988-12-08 1993-08-31 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
GB8828098D0 (en) * 1988-12-01 1989-01-05 Wellcome Found Peptides
GB8828097D0 (en) * 1988-12-01 1989-01-05 Wellcome Found Peptides
DE3901857A1 (de) * 1989-01-23 1990-07-26 Boehringer Mannheim Gmbh Verfahren zur bestimmung von hiv 2 antikoerpern
EP0438332B1 (de) * 1990-01-16 1998-04-08 Orgenics Ltd. Peptide, von Virus-HIV-Hüllen-Glycoproteinen abstammend, deren Verwendung zum Nachweis einer Infektion dieser Viren und für die Impfung gegen AIDS
FR2657016B1 (fr) * 1990-01-16 1995-08-25 Clonatec Sa Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-2, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
WO1991015512A2 (en) * 1990-04-03 1991-10-17 Genentech, Inc. Hiv envelope polypeptides
NZ243636A (en) * 1991-07-29 1993-06-25 Iaf Biochem Int Immunoassay and kit for simultaneously detecting antibodies to hiv-1, hiv-2, htlv-1 and htlv-11
AU671623B2 (en) * 1992-03-06 1996-09-05 N.V. Innogenetics S.A. Process for the determination of peptides corresponding to immunologically important epitopes and biotinylated peptides used therein
JP4278174B2 (ja) * 1994-10-20 2009-06-10 アンスティテュ・パストゥール Hiv−1のoグループ(またはサブグループ)レトロウイルス性抗原のヌクレオチド配列
FR2874017B1 (fr) * 2004-08-06 2006-11-24 Bio Rad Pasteur Sa Peptides vih-1 modifies et leur utilisation en detection d'anticorps anti-vih
EP2778681A1 (de) * 2013-03-15 2014-09-17 Biomay Ag Verfahren zur Diagnose einer Virusinfektion

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
DE3789633T2 (de) * 1986-05-27 1994-08-04 Hoffmann La Roche HTLV-III(LAV)Decke-Peptide.
IE63109B1 (en) * 1986-06-23 1995-03-22 Genetic Systems Corp Human monoclonal antibody to lymphadenopathy-associated virus
NO881151L (no) * 1987-03-27 1988-09-28 Syntello Ab Syntetisk hiv-1-antigen.
EP0309566B1 (de) * 1987-04-16 1994-01-12 Johnson And Johnson Stlv-iii-verwandte polypeptide, diagnosesysteme und testmethoden
JPH0215098A (ja) * 1987-05-18 1990-01-18 Virovahl Sa Hiv−1感染検出用合成ペプチド杭原、その組成物およびその使用方法
AU627701B2 (en) * 1987-10-28 1992-09-03 Euro-Diagnostica Ab Hiv peptides, artificial hiv antigens and immunoassay kits
SE8704185L (sv) * 1987-10-28 1989-04-29 Ferring Ab Nya peptider, artificiella antigener och immunoanalystestsatser

Also Published As

Publication number Publication date
ATE131492T1 (de) 1995-12-15
ES2083387T3 (es) 1996-04-16
EP0326490A3 (en) 1990-07-04
EP0326490B2 (de) 2004-11-24
JP2001055400A (ja) 2001-02-27
DE68925043T2 (de) 1996-08-22
AU2851389A (en) 1989-07-27
DE68925043T3 (de) 2005-07-28
ES2083387T5 (es) 2005-07-01
IL88963A0 (en) 1989-08-15
AU629528B2 (en) 1992-10-08
JP3851761B2 (ja) 2006-11-29
EP0326490A2 (de) 1989-08-02
JPH01224397A (ja) 1989-09-07
JPH08245693A (ja) 1996-09-24
DE68925043D1 (de) 1996-01-25
EP0326490B1 (de) 1995-12-13

Similar Documents

Publication Publication Date Title
CA1336473C (en) Synthetic peptide antigens for the detection of hiv-1 infection
JPH07121959B2 (ja) Htlv−▲iii▼エンベロ−プ蛋白質
EP0326490B1 (de) Synthetische Peptide und deren Mischungen für den Nachweis von HIV-Antikörpern
EP0538283B2 (de) Synthetische peptide und mischungen davon zum nachweis der gegen hiv-gerichteten antikörper
JP2598245B2 (ja) Htlv−iii/lavウイルス関連ペプチドに対する抗体
JP2650217B2 (ja) Htlv―1感染の診断、治療及び予防接種のためのペプチド
JP3390002B2 (ja) Htlv―iおよびhtlv―iiウイルスに対する抗体を検出するためのペプチドおよびアナログおよびその混合物
CA1341594C (en) Synthetic peptides and mixtures therof for detecting hiv antibodies
US6218102B1 (en) Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6210874B1 (en) Synthetic peptides and mixtures thereof for detecting HIV antibodies
US5359029A (en) Peptides and analogues and mixtures thereof for detecting antibodies to HTLV-I and HTLV-II viruses
CA1338028C (en) Synthetic peptide antigens for the detection of hiv-1 infection

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
HS Change of address for service
KB Patent renewed
KB Patent renewed